METTL3-mediated m6A modification stabilizes YOD1 to promote Bcl-xL-dependent enzalutamide resistance in prostate cancer
Resistance to enzalutamide remains a major challenge in advanced prostate cancer, but the mechanisms linking epitranscriptomic regulation to apoptotic escape remain incompletely understood. By integrating MeRIP-seq and RNA-seq analyses of parental and enzalutamide-resistant prostate cancer cells, we identified the deubiquitinase YOD1 as a candidate mediator of resistance. YOD1 depletion enhanced enzalutamide-induced apoptosis and suppressed resistant tumor growth in vitro and in vivo. Mechanistically, METTL3-dependent m6A modification at A1360 promoted the association of YOD1 mRNA with IGF2BP2, thereby enhancing transcript stability and YOD1 expression. YOD1 associated with Bcl-xL and limited its K48-linked ubiquitination and proteasomal degradation. Catalytic-mutant and genetic rescue experiments supported the requirement for YOD1 deubiquitinase activity and positioned Bcl-xL as a functional downstream effector. Pharmacological inhibition of Bcl-xL with A-1,155,463 enhanced the response to enzalutamide in cellular and resistant xenograft models. In addition, immunohistochemical analysis of prostate cancer specimens revealed positive associations among METTL3, YOD1 and Bcl-xL protein abundance. Together, these findings support an m6A-deubiquitinase-Bcl-xL regulatory cascade that contributes to apoptotic resistance during enzalutamide treatment. This pathway may represent a potential therapeutic vulnerability, although its clinical relevance requires further validation.
Authors
- Yueming Chen (ORCID: https://orcid.org/0000-0002-6588-5423)
- Lu Chen (ORCID: https://orcid.org/0000-0002-5775-6947)
- 杨晓群
- Haozhuo Song
- Hai Huang
- Danfeng Xu
- Da Huang
- Guixin Zhang
- Zeping Chen
- Zixian Wang
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Sir Run Run Shaw Hospital (CN)
- Shanghai Institute of Immunology (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Cellular and Molecular Life Sciences
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1007/s00018-026-06518-1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- School of Medicine, Shanghai Jiao Tong University